ELAN Corporation and DuPont Merck Pharmaceutical Company have announced an alliance to co-promote their leading Parkinson's disease drugs in the US.
The alliance will be implemented by the sales force of Elan's wholly-owned subsidiary, Athena Neurosciences and DuPont Merck. The products are Permax and Sinemet CR.
